{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:42:57Z","timestamp":1787240577034,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.vaccine.2010.02.019","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T05:27:47Z","timestamp":1267162067000},"page":"4731-4737","source":"Crossref","is-referenced-by-count":82,"title":["Post-licensure monitoring of HPV vaccine in the United States"],"prefix":"10.1016","volume":"28","author":[{"given":"Lauri E.","family":"Markowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Saraiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Deblina","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen F.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2010.02.019_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1586\/14760584.7.4.437","article-title":"Monitoring the impact of vaccines post-licensure: new opportunities and challenges","volume":"7","author":"Schuchat","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"56 (RR-2)","key":"10.1016\/j.vaccine.2010.02.019_bib2","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the advisory Committee on Immunization Practices (ACIP)","volume":"23","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"19","key":"10.1016\/j.vaccine.2010.02.019_bib3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.02.019_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus A (HPV)-16\/18 ASO4-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA); final analysis of a double-blind, randomized study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.vaccine.2010.02.019_bib5","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"9590","key":"10.1016\/j.vaccine.2010.02.019_bib6","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2010.02.019_bib7","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2010.02.019_bib8","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2010.02.019_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epid Biomarkers Prev"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2010.02.019_bib10","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.vaccine.2006.05.061","article-title":"Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.019_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/phr\/115.1.65","article-title":"National Immunization Survey: the methodology of a vaccination surveillance system","volume":"115","author":"Zell","year":"2000","journal-title":"Public Health Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.019_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/003335490912400506","article-title":"Determining accurate vaccination coverage rates for adolescents: an overview of the methodology used in the National Immunization Survey-Teen 2006","volume":"124","author":"Jain","year":"2009","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2010.02.019_bib13","first-page":"1100","article-title":"Vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2007","volume":"57","author":"CDC","year":"2008","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2010.02.019_bib14","first-page":"997","article-title":"National, state, and local area vaccination coverage among adolescents aged 13\u201317 Years\u2014United States, 2008","volume":"58","author":"CDC","year":"2009","journal-title":"MMWR"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.019_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ypmed.2008.11.010","article-title":"Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007","volume":"48","author":"Jain","year":"2009","journal-title":"Prev Med"},{"issue":"Suppl. 8","key":"10.1016\/j.vaccine.2010.02.019_bib16","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/cncr.23760","article-title":"Human papillomavirus and cervical cancer behavioral surveillance","volume":"1113","author":"Tiro","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2010.02.019_bib17","author":"Schiller"},{"key":"10.1016\/j.vaccine.2010.02.019_bib18","doi-asserted-by":"crossref","unstructured":"Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J, et al. Human papillomavirus vaccination practices: a survey of U.S. physicians 18 months post-licensure. Pediatrics 2010, in press.","DOI":"10.1542\/peds.2009-3500"},{"key":"10.1016\/j.vaccine.2010.02.019_bib19","unstructured":"Food and Drug Administration. Product approval information\u2014licensing action, package insert. GARDASIL\u00ae [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]; http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM111263.pdf."},{"key":"10.1016\/j.vaccine.2010.02.019_bib20","unstructured":"Food and Drug Administration. Product approval information\u2014licensing action, package insert. CERVARIX\u00ae [Human Papillomavirus Bivalent (Types 16, and 18) Vaccine, Recombinant]; http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM186981.pdf."},{"issue":"9","key":"10.1016\/j.vaccine.2010.02.019_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3928\/0090-4481-20040901-11","article-title":"The role of the vaccine adverse event reporting system (VAERS) in monitoring vaccine safety","volume":"33","author":"Iskander","year":"2004","journal-title":"Pediatr Ann"},{"issue":"ss01","key":"10.1016\/j.vaccine.2010.02.019_bib22","first-page":"1","article-title":"Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)\u2014United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.019_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.613","article-title":"Vaccine Safety Datalink Research Group. The Vaccine Safety Datalink project","volume":"10","author":"DeStefano","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10 Suppl. 2","key":"10.1016\/j.vaccine.2010.02.019_bib24","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events","volume":"45","author":"Lieu","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2010.02.019_bib25","unstructured":"Bonanni P, Cohet C, Kjaer SK, Latham, N, Lambert PH, Reisinger K, Haupt RM. A summary of the post-licensure surveillance initiatives for GARDASIL\/SILGARD\u00ae. Vaccine, in press."},{"issue":"7","key":"10.1016\/j.vaccine.2010.02.019_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus (Types 6, 11, 16, 18) recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.019_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2010.02.019_bib28","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/cncr.23758","article-title":"Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods","volume":"113","author":"Watson","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2010.02.019_bib29","series-title":"Proceedings of the 18th International Society for Sexually Transmitted Diseases Research (ISSTDR) Congress","article-title":"Estimates of the timing of population-level reductions in HPV-related health outcomes after onset of HPV vaccination (Abstract)","author":"Chesson","year":"2009"},{"issue":"3","key":"10.1016\/j.vaccine.2010.02.019_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive carcinoma and high grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2010.02.019_bib31","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1002\/cncr.23755","article-title":"Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role","volume":"113","author":"Saraiya","year":"2008","journal-title":"Cancer"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2010.02.019_bib32","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1002\/cncr.23747","article-title":"Total burden and incidence of in situ and invasive cervix cancer in Michigan, 1985\u20132003","volume":"113","author":"Copeland","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2010.02.019_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","article-title":"Diagnoses and outcomes in cervical cancer screening: a population-based study","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.019_bib34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2010.02.019_bib35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6,11,16, and 18) vaccine","volume":"199","author":"Garland","year":"2008","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2010.02.019_bib36","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"36","author":"Insigna","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2010.02.019_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.olq.0000253337.62932.29","article-title":"Potential impact of human papillomavirus vaccines on public STD clinic workloads and on opportunities to diagnose and treat other sexually transmitted diseases","volume":"34","author":"Dempsey","year":"2007","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2010.02.019_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0b013e3181632d61","article-title":"Genital warts among 18\u201359 year olds in the United States, National Health and Nutrition Examination Survey\u20141999\u20132004","volume":"35","author":"Dinh","year":"2008","journal-title":"Sex Trans Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2010.02.019_bib39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2010.02.019_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-148-7-200804010-00004","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"Datta","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2010.02.019_bib41","first-page":"289","article-title":"Immunization information systems progress\u2014United States, 2006","volume":"57","year":"2008","journal-title":"MMWR"},{"issue":"9580","key":"10.1016\/j.vaccine.2010.02.019_bib42","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2010.02.019_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnci\/djn019","article-title":"Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination","volume":"100","author":"Goldhaber-Fiebert","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.vaccine.2010.02.019_bib44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ogc.2008.09.005","article-title":"Cervical cancer screening in the early post-vaccine era","volume":"35","author":"Waxman","year":"2008","journal-title":"Obstet Gynecol Clin N Am"},{"key":"10.1016\/j.vaccine.2010.02.019_bib45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1158\/1055-9965.EPI-07-2629","article-title":"Accuracy of self-reported cancers screening histories: a meta-analysis","volume":"17","author":"Rauscher","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2010.02.019_bib46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cncr.20513","article-title":"Some methodologic lessons learned from cancer screening research","volume":"101","author":"Vernon","year":"2004","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.vaccine.2010.02.019_bib47","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archotol.129.9.976","article-title":"National registry for juvenile-onset recurrent respiratory papillomatosis","volume":"129","author":"Reeves","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"7","key":"10.1016\/j.vaccine.2010.02.019_bib48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2010.02.019_bib49","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/j.vaccine.2006.05.109","article-title":"Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries","volume":"24","author":"Lehtinen","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10001878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10001878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T13:23:40Z","timestamp":1590672220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10001878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":49,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0264410X10001878"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}